REFRAMING WOMEN’S HEALTH AS A SYSTEM-WIDE AGENDA ACROSS INNOVATION, REGULATION, WORKFORCE AND POLICY
With
Professor Robyn Norton AO
Founding Director, The George Institute for Global Health &
Professor of Public Health,
Faculty of Medicine, UNSW Sydney &
Emeritus Professor, Imperial College London
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Sydney | July 2026
In May 2026, Professor Robyn Norton AO, played a prominent role at the inaugural Medical Technology Association of Australia (MTAA) Women’s Health MedTech Summit, Breaking the Silos, held in Sydney.
Professor Robyn Norton AO FAHMS is one of the two Founding Directors of The George Institute for Global Health, Professor of Public Health at UNSW Sydney and Emeritus Professor of Global Health at Imperial College London. Robyn co-established The George Institute’s Global Women’s Health Program and more recently the Centre for Sex and Gender Equity in Health and Medicine, where she co-leads the Business Translation Working Group. Robyn is a director on the board of the Black Dog Institute, a member of the Women in MedTech Committee of the MTAA and a member of Chief Executive Women. She also chairs the NHMRC’s Gender Guidelines Development Committee and the Advisory Board of the Network of Excellence in Women’s Health at Imperial College London.
Suiting her significant contribution to global health research, her involvement extended beyond being a keynote speaker—she helped frame the strategic direction of the summit and the broader conversation around women’s health innovation in Australia.
The summit itself was designed to address longstanding gaps in women’s health research, medical technology, clinical trials and policy by bringing together clinicians, researchers, industry, investors, government and consumer advocates. Following the event, MTAA reported that almost 200 participants attended and used the discussions to inform a Women’s Health Action Plan aimed at driving future MedTech policy and innovation.
Australian Health Journal spoke with Professor Norton on her research journey, the early stages of the George Institute for Global Health and the priorities for advancing women’s health.
Source: Adapted from MTAA Women’s Health MedTech Summit speaker profile and agenda
Media access credit: Medical Technology Association of Australia (MTAA)
-
Global MedTech company brings device reprocessing plant to Australia
Cardinal Health is global medical products manufacturer and leading provider of single-use device reprocessing services in the U.S. In Australia and New Zealand, as one of the largest suppliers of medical devices, announced on 23 May 2024 that it will be opening a single-use medical device reprocessing facility in Australia – its first reprocessing facility outside the United States.
On 18 March 2025 at the Health Innovation Living Lab at the John Hunter Hospital, a further announcement was made, on the chosen single-use medical device remanufacturing facility in Beresfield, Newcastle, set to commence operation late 2025, supported by the NSW Department of Primary Industries and Regional Development.
-
Reporting on Australian childhood visual impairment: the first 10 years
The Australian Childhood Vision Impairment Register (ACVIR), the first of its kind in Australia, captures uniquely Australian data which is used to improve services for children with vision impairment. The data is also available to researchers who work in the area of eye disease and disorders of vision.
-
Landmark research projects tackle critical issues in emergency healthcare
For two decades, the demand for emergency department services in Australia has outpaced population growth and wait times have increased. In 2022-2023 more than 8.8 million emergency department presentations occurred nationwide.
While demand is a contributing factor, EDs are currently being impacted by various factors across the entire health system.
The Emergency Medicine Foundation (EMF) is a non-profit organisation funding innovative Australian research that improves the way people are cared for in a medical emergency. The aim of the research is to deliver better and more effective health services to save lives and money.
